$14.73
0.51% yesterday
NYSE, Sep 26, 10:00 pm CET
ISIN
US8740602052
Symbol
TAK

Takeda Pharmaceutical Co. Ltd. Sponsored ADR Stock price

$14.74
-0.14 0.94% 1M
-0.28 1.86% 6M
+1.50 11.33% YTD
+0.09 0.61% 1Y
+1.93 15.07% 3Y
-4.25 22.38% 5Y
-7.55 33.88% 10Y
-12.61 46.11% 20Y
NYSE, Closing price Fri, Sep 26 2025
+0.09 0.61%
ISIN
US8740602052
Symbol
TAK
Industry

Key metrics

Basic
Market capitalization
$47.1b
Enterprise Value
$74.4b
Net debt
$27.3b
Cash
$2.8b
Shares outstanding
1.6b
Valuation (TTM | estimate)
P/E
25.0 | 14.2
P/S
1.6 | 1.5
EV/Sales
2.5 | 2.4
EV/FCF
13.6
P/B
1.0
Dividends
DPS
$0.67
Yield 1Y | 5Y
4.5% | 4.5%
Growth 1Y | 5Y
8.8% | -4.3%
Payout 1Y | 3Y
144.6% | 78.8%
Increased
1 Year
Financials (TTM | estimate)
Revenue
$30.0b | $30.7b
EBITDA
$6.5b | $8.2b
EBIT
$2.8b | $2.7b
Net Income
$915.5m | $1.6b
Free Cash Flow
$5.5b
Growth (TTM | estimate)
Revenue
1.5% | 0.2%
EBITDA
2.3% | 11.0%
EBIT
1.0% | -25.2%
Net Income
-8.7% | 125.3%
Free Cash Flow
84.1%
Margin (TTM | estimate)
Gross
64.8%
EBITDA
21.7% | 26.6%
EBIT
9.3%
Net
3.1% | 5.3%
Free Cash Flow
18.3%
Financial Health
Equity Ratio
48.7%
Return on Equity
1.6%
ROCE
3.5%
ROIC
2.6%
Debt/Equity
0.7
More
EPS
$0.6
FCF per Share
$3.5
Short interest
0.2%
Employees
49k
Rev per Employee
$620.0k
Show more

Is Takeda Pharmaceutical Co. Ltd. Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

Takeda Pharmaceutical Co. Ltd. Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Takeda Pharmaceutical Co. Ltd. Sponsored ADR forecast:

11x Buy
55%
9x Hold
45%

Analyst Opinions

20 Analysts have issued a Takeda Pharmaceutical Co. Ltd. Sponsored ADR forecast:

Buy
55%
Hold
45%

Financial data from Takeda Pharmaceutical Co. Ltd. Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
29,955 29,955
2% 2%
100%
- Direct Costs 10,550 10,550
6% 6%
35%
19,405 19,405
1% 1%
65%
- Selling and Administrative Expenses 7,292 7,292
1% 1%
24%
- Research and Development Expense 4,718 4,718
4% 4%
16%
6,505 6,505
2% 2%
22%
- Depreciation and Amortization 3,705 3,705
3% 3%
12%
EBIT (Operating Income) EBIT 2,799 2,799
1% 1%
9%
Net Profit 915 915
9% 9%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Takeda Pharmaceutical Co. Ltd. Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Takeda Pharmaceutical Co. Ltd. Sponsored ADR Stock News

Negative
Reuters
one day ago
Shares of Asian drugmakers mostly fell on Friday after U.S. President Donald Trump threatened 100% tariffs on imports of branded pharmaceuticals from October 1, unless their producers had already broken ground on U.S. manufacturing plants.
Positive
Seeking Alpha
3 days ago
Takeda (TAK) offers a compelling investment case with six late-stage therapies targeting $20 billion in peak sales by 2030-31. TAK's pipeline includes first-in-class and best-in-class candidates, but faces commercialization and competitive risks, especially with high debt levels. Financial restructuring, margin expansion, and debt reduction are critical for TAK's valuation recovery and future d...
Neutral
Business Wire
4 days ago
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE: TAK) today committed JPY 4.6 billion (approx. USD 32.1 million) to four new Global Corporate Social Responsibility (CSR) partners as part of the company's ongoing commitment to building climate-resilient health systems in low- and middle-income countries around the world. Amid rising temperatures and extreme weather even...
More Takeda Pharmaceutical Co. Ltd. Sponsored ADR News

Company Profile

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Head office Japan
CEO Christophe Weber
Employees 49,281
Founded 1781
Website www.takeda.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today